U.S. study suggests vaccines may be ineffective against Omicron without booster | Reuters
Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants | Nature Medicine
Moderna on LinkedIn: #covid19 #omicron #booster #antibody #mrna | 14 comments
Pfizer says COVID booster offers protection against omicron | AP News
Reduced sensitivity of SARS-CoV-2 Omicron variant to antibody neutralization elicited by booster vaccination | Cell Discovery
Neutralization of SARS-CoV-2 Omicron sub-lineages BA.1, BA.1.1, and BA.2 - ScienceDirect
Vaccines | Free Full-Text | Is Booster Dose Strategy Sufficient for Omicron Variant of SARS-CoV-2?
Protective antibodies and T cell responses to Omicron variant after the booster dose of BNT162b2 vaccine - ScienceDirect
Effectiveness of BNT162b2 third dose against Omicron-associated severe disease
Omicron: Moderna says booster of its Covid vaccine increases protection
Three-dose vaccination-induced immune responses protect against SARS-CoV-2 Omicron BA.2: a population-based study in Hong Kong - The Lancet Regional Health – Western Pacific
COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence — 25 U.S. Jurisdictions, April 4–December 25, 2021 | MMWR
Vaccines appear weak at blocking Omicron, better against severe disease | Reuters
Covid booster vaccines effective against severe illness from omicron, CDC says
Study estimates effectiveness of 2-dose and 3-dose mRNA vaccination against Omicron
3 COVID vaccine doses appear to protect against Omicron subvariants | CIDRAP
Systematic review of primary and booster COVID-19 sera neutralizing ability against SARS-CoV-2 omicron variant | npj Vaccines
Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron Infection | NEJM
Effectiveness of a third dose of BNT162b2 mRNA COVID-19 vaccine in a large US health system: A retrospective cohort study - The Lancet Regional Health – Americas
Vaccines | Free Full-Text | The Four Ws of the Fourth Dose COVID-19 Vaccines: Why, Who, When and What
COVID-19 vaccine booster dose needed to achieve Omicron-specific neutralisation in nursing home residents - eBioMedicine
Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron | NEJM
Timely booster vaccination reduces omicron breakthrough infections and COVID-19 severity
Moderna starts trial for Omicron-specific booster shot | Reuters
Pfizer seeks FDA authorization of updated COVID-19 shot for kids under 5 | PBS NewsHour
FDA approves 2nd omicron booster for high-risk people
